Botulinum toxin and human serum albumin

Arch Ophthalmol. 2003 Nov;121(11):1661; discussion 1661-2. doi: 10.1001/archopht.121.11.1661-a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / chemistry
  • Botulinum Toxins, Type A / therapeutic use*
  • Drug Labeling / legislation & jurisprudence
  • Drug Therapy, Combination
  • Humans
  • Informed Consent
  • Legislation, Drug
  • Neuromuscular Agents / adverse effects
  • Neuromuscular Agents / chemistry
  • Neuromuscular Agents / therapeutic use*
  • Pharmaceutical Preparations
  • Prion Diseases / transmission*
  • Risk Factors
  • Serum Albumin / adverse effects
  • Serum Albumin / chemistry
  • Serum Albumin / therapeutic use*
  • United States
  • United States Food and Drug Administration
  • Virus Diseases / transmission*

Substances

  • Neuromuscular Agents
  • Pharmaceutical Preparations
  • Serum Albumin
  • Botulinum Toxins, Type A